SCOPUS 정보 검색 플랫폼

Volumn 54, Issue 4, 2000, Pages 973-975

Stable weight during lamotrigine therapy: A review of 32 studies

Author keywords

Antiepileptic drugs; Body weight; Lamotrigine

Indexed keywords

LAMOTRIGINE;

ADULT; ARTICLE; BODY WEIGHT; DRUG EFFECT; DRUG SCREENING; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0034700992 PISSN: 00283878 EISSN: None Source Type: Journal
DOI: 10.1212/WNL.54.4.973 Document Type: Article

Times cited : (66)

References (10)

1
- 0019494319
- Effects of sodium valproate in 100 children with special reference to weight
- Egger J, Brett EM. Effects of sodium valproate in 100 children with special reference to weight. BMJ 1981;283:577-581.
- (1981) BMJ , vol.283 , pp. 577-581
- Egger, J.¹ Brett, E.M.²

2
- 0030852379
- Weight gain in epileptic patients during treatment with valproic acid: A retrospective study
- Corman CL, Leung NM, Guberman AH. Weight gain in epileptic patients during treatment with valproic acid: a retrospective study. Can J Neurol Sci 1997;24:240-244.
- (1997) Can J Neurol Sci , vol.24 , pp. 240-244
- Corman, C.L.¹ Leung, N.M.² Guberman, A.H.³

3
- 0025740492
- Weight gain, increased appetite, and excessive food intake induced by carbamazepine
- Lampl Y, Eshel Y, Rapaport A, Sarova-Pinhas I. Weight gain, increased appetite, and excessive food intake induced by carbamazepine. Clin Neuropharmacol 1991;14:251-255.
- (1991) Clin Neuropharmacol , vol.14 , pp. 251-255
- Lampl, Y.¹ Eshel, Y.² Rapaport, A.³ Sarova-Pinhas, I.⁴

4
- 0029967145
- Bodyweight change as an adverse effect of drug treatment: Mechanisms and management
- Pijl H, Meinders AE. Bodyweight change as an adverse effect of drug treatment: mechanisms and management. Drug Saf 1996;14:329-342.
- (1996) Drug Saf , vol.14 , pp. 329-342
- Pijl, H.¹ Meinders, A.E.²

5
- 0027437262
- Medical hazards of obesity
- Pi-Sunyer F. Medical hazards of obesity. Ann Intern Med 1993;119(7 pt 2):655-660.
- (1993) Ann Intern Med , vol.119 , Issue.7 PT 2 , pp. 655-660
- Pi-Sunyer, F.¹

6
- 0030758080
- Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril)
- Lambert MV, Bird JM. Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril). Seizure 1997;6:233-235.
- (1997) Seizure , vol.6 , pp. 233-235
- Lambert, M.V.¹ Bird, J.M.²

7
- 0029884009
- Obesity and endocrine disorders in women taking valproate for epilepsy
- Isojarvi JIT, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KTS, Myllyla VV. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996;39: 579-584.
- (1996) Ann Neurol , vol.39 , pp. 579-584
- Isojarvi, J.I.T.¹ Laatikainen, T.J.² Knip, M.³ Pakarinen, A.J.⁴ Juntunen, K.T.S.⁵ Myllyla, V.V.⁶

8
- 0031405115
- Changes in body weight with chronic, high-dose gabapentin therapy
- DeToledo JC, Toledo C, DeCerce J, Ramsey RE. Changes in body weight with chronic, high-dose gabapentin therapy. Ther Drug Monitor 1997;19:394-396.
- (1997) Ther Drug Monitor , vol.19 , pp. 394-396
- DeToledo, J.C.¹ Toledo, C.² DeCerce, J.³ Ramsey, R.E.⁴

9
- 0028854393
- Weight loss in patients taking felbamate
- Bergen DC, Ristanovic RK, Waicosky K, Kanner A, Hoeppner TJ. Weight loss in patients taking felbamate. Clin Neuropharmacol 1995;18:23-27.
- (1995) Clin Neuropharmacol , vol.18 , pp. 23-27
- Bergen, D.C.¹ Ristanovic, R.K.² Waicosky, K.³ Kanner, A.⁴ Hoeppner, T.J.⁵

10
- 0031820935
- Topiramate - Safety, tolerability
- Jones MW. Topiramate - safety, tolerability. Can J Neurol Sci 1998;25:S13-S15.
- (1998) Can J Neurol Sci , vol.25
- Jones, M.W.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.